CLINICAL_TRIALS
trial_result
· 2021-01-15
Clinical Trial Update: Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Summary
Phase 2 clinical trial update for perampanel in sporadic amyotrophic lateral sclerosis (ALS) has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tokyo Medical University | Conditions: ALS | Phase 2 | Status: COMPLETED